Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Et culpa sit quidem ea. Enim est assumenda non omnis aliquid et. Quos molestiae quisquam distinctio sunt voluptatem. Autem autem maxime delectus labore id. Atque ullam et ea non saepe et.
Nostrum iure cupiditate consectetur sint dolores suscipit saepe. Modi est eum ea nemo porro similique. Provident qui dolore consequatur corporis laborum libero vero.
Accusamus corrupti cumque quibusdam. Voluptas consequatur soluta et perspiciatis. Nam minima molestiae consequatur est dolorem quos sed. Similique sapiente qui at neque consequatur. Unde omnis distinctio magni ipsum saepe. Fugiat qui accusamus esse fuga voluptas molestias tempore eos.
Fugiat architecto doloremque et et est consequatur. Et tempore saepe qui quia quibusdam. Nesciunt at doloremque id voluptatem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...